Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Although originally developed for the treatment of hypertension, alpha(2)-agonists have been used to treat Tourette's syndrome, attention-deficit hyperactivity disorder (ADHD), developmental disorders and substance abuse for nearly three decades. Based on studies of clonidine, alpha(2)-agonists were presumed to reduce arousal by decreasing the firing of noradrenaline neurons in locus ceruleus. Accumulated preclinical evidence indicates that guanfacine has features in common with clonidine, in addition to other pharmacological effects. Clonidine binds to the three subtypes of alpha(2)-receptors, A, B and C, whereas guanfacine binds more selectively to alpha(2A)-receptors, which appears to enhance prefrontal function. Several reports on the use of the alpha(2)-agonists show improvements in children with ADHD and improvements in hyperactivity, impulsiveness and inattention in children with tic disorders and pervasive developmental disorders. Both clonidine and guanfacine are associated with sedation, fatigue and somnolence. Reductions in heart rate and blood pressure are modest and rarely lead to discontinuation of treatment across these trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, “sluggish” can be perceived as derogatory or implying laziness or low intelligence,12,172”
From Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome (2023) · cites this paper as [172]
In the citing paper
“clonidine may be theoretically less likely than guanfacine to provide benefit in individuals with CDS as it is generally more sedating [65]”
In the citing paper
“Compared to clonidine, guanfacine appears to bind more selectively to postsynaptic prefrontal a (2A)-receptors to enhance functioning of prefrontal cortex.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [125]
Citations
Cites
(1985) · PubMed · Cited by 1,427
Rubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00275-1 · Cited by 852
Clonidine blocks acute opiate-withdrawal symptoms
Gold, M., Redmond, D. E., & Kleber, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92823-4 · Cited by 710
Wang, M., Ramos, B. P., Paspalas, C. D., Shu, Y., Simen, A., Duque, A., Vijayraghavan, S., Brennan, A., Dudley, A., Nou, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.015 · Cited by 672
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1088 · Cited by 652
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Self-citationTreatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
THALIDOMIDE AND LIMB DEFORMITIES
Millen, J. (1962) · The Lancet · doi:10.1016/s0140-6736(62)90462-2 · Cited by 462
Arnsten, A. F. T. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050084013 · Cited by 458
Jensen, P. N., Arnold, L. E., Richters, J., Severe, J. B., Vereen, D. R., Vitiello, B., Schiller, E., Hinshaw, S. P., Elliott, G. R., Conners, C., et al. (1999) · Institutional Research Information System University of Turin (University of Turin) · Cited by 432
Research works printed but not linked: 1
- Aman, 1985, Am J Ment Defic, 89, 485
Cited by
Projection-Specific Neuromodulation of Medial Prefrontal Cortex Neurons
Dembrow, N. C., Chitwood, R. A., & Johnston, D. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3644-10.2010 · Cited by 285
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder
Croxtall, J. D. (2011) · Pediatric Drugs · doi:10.2165/11208100-000000000-00000 · Cited by 190
Becker, S. P., Willcutt, E. G., Leopold, D. R., Fredrick, J. W., Smith, Z. R., Jacobson, L. A., Burns, G. L., Mayes, S. D., Waschbusch, D. A., Froehlich, T. E., et al. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2022.07.821 · Cited by 175
Wigal, S. B. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00004 · Cited by 166
Metadata
- Authors
- Scahill, L.
- Affiliations
- Yale University (US)
- Corresponding author
- Scahill, Lawrence
- ORCID
- Scahill, Lawrence
- Venue
- CNS Drugs
- Published
- 2009-09
- Volume
- 23
- Issue
- Supplement 1
- Pages
- 43-49
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W2101821137
- Cited by
- 58
- References
- 38
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 2 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 7 · 2012: 9
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- alpha-2 adrenergic agonists, clonidine, guanfacine, attention deficit hyperactivity disorder, children, hyperactivity, impulsivity, inattention, Tourette syndrome, tic disorders, pervasive developmental disorders, locus coeruleus, norepinephrine, prefrontal function, sedation, blood pressure
- MeSH terms
- Adrenergic alpha-Agonists, Attention Deficit Disorder with Hyperactivity, Child, Child Development Disorders, Pervasive, Child, Preschool, Clonidine, Humans, Impulsive Behavior, Guanfacine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness. https://app.cochat.ai/papers/10.2165/00023210-200923000-00006
- The paper
- Scahill, L. (2009). Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness. CNS Drugs. https://doi.org/10.2165/00023210-200923000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.